Ascenta Capital
Status
ACTIVE
Global HQ
Wilmington, United States
Countries of investment
- United States
Investment stages
- Series A
- Series B
Industries
- Biotechnology
- Health Tech
- Life Sciences
- Pharma
About
Ascenta Capital focuses on advancing biotech companies through Phase 1 and Phase 2 clinical development. The firm provides strategic capital and operational support to help high-potential therapeutics reach key inflection points and prepare for later-stage partnerships or exits.
Ascenta Capital focuses on advancing biotech companies through Phase 1 and Phase 2 clinical development. The firm provides strategic capital and operational support to help high-potential therapeutics reach key inflection points and prepare for later-stage partnerships or exits.
Investment Thesis
Ascenta Capital invests in development-stage biotechnology companies with strong clinical potential in the United States.
Manager's Experience
The leadership team has over 15 years of experience in biotech venture capital and corporate finance, with a focus on clinical-stage investments and value creation through science-driven companies.
Team
EVAN RACHLIN
MD – Co-Founder and Managing Partner
LORENCE KIM
MD – Co-Founder and Managing Partner
JEFF CHODAKEWITZ
MD – Advisory Partner
Portfolio
Belharra Therapeutics
Tectonic Therapeutic
ROME Therapeutics